SLXN CIK: 2022416

Silexion Therapeutics Corp

  • Israel
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY23
FY24
FY25
FY23 – FY25

Assets

(positive)
Change from FY23 to FY25
millions USD
FY23:
4.98
FY24:
2.25
FY25:
6.64
(positive)
Change from FY23 to FY25
millions USD
FY23:
0.28
FY24:
0.61
FY25:
0.58
Total assets
Change from FY23 to FY25
millions USD
FY23:
5.26
FY24:
2.86
FY25:
7.22

Liabilities & Equity

(negative)
Change from FY23 to FY25
millions USD
FY23:
2.20
FY24:
3.52
FY25:
2.76
(negative)
Change from FY23 to FY25
millions USD
FY23:
0.06
FY24:
3.33
FY25:
1.85
(positive)
Change from FY23 to FY25
millions USD
FY23:
−15.5
FY24:
−3.99
FY25:
2.60
Total liabilities & equity
Change from FY24 to FY25
millions USD
FY23:
–
FY24:
2.86
FY25:
7.22

All amounts in millions USD Data source:SEC EDGAR